Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bowles

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
BMC Cancer|March 29, 2019
Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort studyErin J A Bowles, Onchee Yu, Rebecca Ziebell, et al.
Pediatric Blood & Cancer|November 13, 2021
Positive predictive value and sensitivity of ICD-9-CM codes for identifying pediatric leukemiaSheila Weinmann, Melanie C Francisco, Marilyn L Kwan, et al.
Plos One|September 6, 2023
Medical imaging utilization and associated radiation exposure in children with down syndromeEmily C Marlow, Jonathan M Ducore, Marilyn L Kwan, et al.
JAMA Network Open|November 20, 2020
Trends in Imaging for Suspected Pulmonary Embolism Across US Health Care Systems, 2004 to 2016Ralph C Wang, Diana L Miglioretti, Emily C Marlow, et al.
Cancer|February 15, 2023
Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor statusKathryn P Lowry, Laura Ichikawa, Rebecca A Hubbard, et al.
Journal of the National Cancer Institute|October 30, 2024
Supplemental breast cancer screening after negative mammography in US women with dense breastsVictoria M Foster, Amy Trentham-Dietz, Natasha K Stout, et al.
Journal of Breath Research|August 21, 2019
Volatile organic compound (VOC) emissions of CHO and T cells correlate to their expansion in bioreactorsMitchell M McCartney, Mei S Yamaguchi, Paul A Bowles, et al.
Molecular Immunology|December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytesJehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
The Journal of Pediatrics|March 8, 2021
Leukemia Risk in a Cohort of 3.9 Million Children with and without Down SyndromeEmily C Marlow, Jonathan Ducore, Marilyn L Kwan, et al.
Annals of Internal Medicine|September 2, 2024
Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium CohortDiana L Miglioretti, Linn Abraham, Brian L Sprague, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
BMC Cancer|March 29, 2019
Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort studyErin J A Bowles, Onchee Yu, Rebecca Ziebell, et al.
Pediatric Blood & Cancer|November 13, 2021
Positive predictive value and sensitivity of ICD-9-CM codes for identifying pediatric leukemiaSheila Weinmann, Melanie C Francisco, Marilyn L Kwan, et al.
Plos One|September 6, 2023
Medical imaging utilization and associated radiation exposure in children with down syndromeEmily C Marlow, Jonathan M Ducore, Marilyn L Kwan, et al.
JAMA Network Open|November 20, 2020
Trends in Imaging for Suspected Pulmonary Embolism Across US Health Care Systems, 2004 to 2016Ralph C Wang, Diana L Miglioretti, Emily C Marlow, et al.
Cancer|February 15, 2023
Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor statusKathryn P Lowry, Laura Ichikawa, Rebecca A Hubbard, et al.
Journal of the National Cancer Institute|October 30, 2024
Supplemental breast cancer screening after negative mammography in US women with dense breastsVictoria M Foster, Amy Trentham-Dietz, Natasha K Stout, et al.
Journal of Breath Research|August 21, 2019
Volatile organic compound (VOC) emissions of CHO and T cells correlate to their expansion in bioreactorsMitchell M McCartney, Mei S Yamaguchi, Paul A Bowles, et al.
Molecular Immunology|December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytesJehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
The Journal of Pediatrics|March 8, 2021
Leukemia Risk in a Cohort of 3.9 Million Children with and without Down SyndromeEmily C Marlow, Jonathan Ducore, Marilyn L Kwan, et al.
Annals of Internal Medicine|September 2, 2024
Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium CohortDiana L Miglioretti, Linn Abraham, Brian L Sprague, et al.
Pageof 16